The trend of 10-year cardiovascular risk among diabetic and non-diabetic participants in Tehran Lipid and glucose study: 1999-2018

被引:1
|
作者
Koohi, Fatemeh [1 ]
Kohansal, Karim [2 ]
Naz, Marzieh Saei Ghare [3 ]
Derakhshan, Somayeh [4 ]
Azizi, Fereidoun [5 ]
Khalili, Davood [2 ]
机构
[1] Shahid Beheshti Univ Med Sci, Obes Res Ctr, Res Inst Endocrine Sci, Tehran, Iran
[2] Shahid Beheshti Univ Med Sci, Res Inst Endocrine Sci, Prevent Metab Disorders Res Ctr, Tehran, Iran
[3] Shahid Beheshti Univ Med Sci, Reprod Endocrinol Res Ctr, Res Inst Endocrine Sci, Tehran, Iran
[4] Shahid Beheshti Univ Med Sci, Sch Publ Hlth & Safety, Dept Epidemiol, Tehran, Iran
[5] Shahid Beheshti Univ Med Sci, Endocrine Res Ctr, Res Inst Endocrine Sci, Tehran, Iran
关键词
Cardiovascular risk score; Risk factors; Diabetes; Trend; Cohort study; DISEASE; POPULATION; EPIDEMIOLOGY; COUNTRY; IRAN;
D O I
10.1186/s12889-022-12981-9
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Background Assessing the risk of cardiovascular disease (CVD) is crucial in preventive cardiology. We aimed to determine the trend of CVD risk among individuals with and without diabetes during two decades of follow-up in a Middle Eastern cohort. Methods We studied 8,450 individuals (55.5% women) aged 40-75 years who participated in the Tehran Lipid and Glucose Study (TLGS). Diabetes status and CVD risk factors were evaluated in six examinations from 1999 to 2018. The individual 10-year CVD risk score was calculated using the ACC/AHA recommended risk equation. We used generalized estimating equation models (GEE) to assess the time trends of CVD risk factors and CVD risk scores in diabetic and non-diabetic groups separately. Results The age-adjusted ACC/AHA risk score significantly decreased in non-diabetic women and men (from 3.2% to 1.6% in women and 6.8% to 5.0% in men; p for trend < 0.001). Whereas the risk significantly decreased among diabetics men (from 13.8% to 11.5%), it increased somehow among diabetics women (from 5.3% to 5.5%). Furthermore, in both sexes, diabetic individuals compared to non-diabetic ones had better control on their systolic blood pressure, total cholesterol, and fasting plasma glucose during the last two decades. Conclusions The CVD risk and most CVD risk factors improved in individuals with and without diabetes in the past two decades; however, they have not reached the targets yet. So, more stringent lifestyle modifications and treatment strategies are needed, especially for primary prevention in the general population.
引用
收藏
页数:9
相关论文
共 50 条
  • [31] A progressive increase in cardiovascular risk assessed by coronary angiography in non-diabetic patients at sub-diabetic glucose levels
    Schinner, Sven
    Fueth, Reiner
    Kempf, Kerstin
    Martin, Stephan
    Willenberg, Holger S.
    Schott, Matthias
    Dinh, Wilfried
    Scherbaum, Werner A.
    Lankisch, Mark
    CARDIOVASCULAR DIABETOLOGY, 2011, 10
  • [32] Air Pollution and Glucose Metabolism: An Analysis in Non-Diabetic Participants of the Heinz Nixdorf Recall Study
    Lucht, Sarah A.
    Hennig, Frauke
    Matthiessen, Clara
    Ohlwein, Simone
    Icks, Andrea
    Moebus, Susanne
    Joeckel, Karl-Heinz
    Jakobs, Hermann
    Hoffmann, Barbara
    ENVIRONMENTAL HEALTH PERSPECTIVES, 2018, 126 (04) : 047001 - 1
  • [33] Clinical outcomes of isolated lower extremity or foot burns in diabetic versus non-diabetic patients: A 10-year retrospective analysis
    Kimball, Zachary
    Patil, Sachin
    Mansour, Hani
    Marano, Michael A.
    Petrone, Sylvia J.
    Chamberlain, Ronald S.
    BURNS, 2013, 39 (02) : 279 - 284
  • [34] Diabetic population mortality and cardiovascular risk attributable to hypertension: A decade follow-up from the Tehran Lipid and Glucose Study
    Bozorgmanesh, Mohammadreza
    Hadaegh, Farzad
    Mohebi, Reza
    Ghanbarian, Arash
    Eskandari, Fatemeh
    Azizi, Fereidoun
    BLOOD PRESSURE, 2013, 22 (05) : 317 - 324
  • [35] The trend of correlation changes of macronutrient intakes among different familial pairs: a prospective study among participants of Tehran Lipid and Glucose Study
    Teymoori, Farshad
    Saber, Niloufar
    Akbarzadeh, Mahdi
    Farhadnejad, Hossein
    Mokhtari, Ebrahim
    Ahmadirad, Hamid
    Riahi, Parisa
    Mirmiran, Parvin
    Daneshpour, Maryam S.
    Azizi, Fereidoun
    BMC PUBLIC HEALTH, 2024, 24 (01)
  • [36] Effect of simvastatin and/or pioglitazone on adiponectin, proinsulin and glucose metabolism in non-diabetic patients at cardiovascular risk -: the PIOSTAT Study
    Wilhelm, B.
    Forst, T.
    Luebben, G.
    Pfuetzner, A.
    Koehler, C.
    Hanefeld, M.
    Karagiannis, E.
    DIABETOLOGIA, 2006, 49 : 70 - 71
  • [37] Fasting plasma glucose in non-diabetic participants and the risk for incident cardiovascular events, diabetes, and mortality: results from WOSCOPS 15-year follow-up†
    Preiss, David
    Welsh, Paul
    Murray, Heather M.
    Shepherd, James
    Packard, Chris
    Macfarlane, Peter
    Cobbe, Stuart
    Ford, Ian
    Sattar, Naveed
    EUROPEAN HEART JOURNAL, 2010, 31 (10) : 1230 - 1236
  • [38] Risk factors for cardiovascular disease and mortality events in adults with type 2 diabetes-a 10-year follow-up: Tehran Lipid and Glucose Study
    Afsharian, Sheila
    Akbarpour, Samaneh
    Abdi, Hengameh
    Sheikholeslami, Farhad
    Moeini, Ali Siamak
    Khalili, Davood
    Momenan, Amir Abbas
    Azizi, Fereidoun
    Hadaegh, Farzad
    DIABETES-METABOLISM RESEARCH AND REVIEWS, 2016, 32 (06) : 596 - 606
  • [39] Is persistence of metabolic syndrome associated with poor health-related quality of life in non-diabetic Iranian adults? Tehran Lipid and Glucose Study
    Amiri, Parisa
    Hosseinpanah, Farhad
    Jalali-Farahani, Sara
    Mehrabi, Yadollah
    Montazeri, Ali
    Azizi, Fereidoun
    JOURNAL OF DIABETES INVESTIGATION, 2014, 5 (06) : 687 - 693
  • [40] Weight associated cardiovascular risk factors in non-diabetic population - the Sankt Georgen Study
    Jacob, S
    Probst, J
    Keulen, L
    Jacob, F
    Winkler, K
    Balletshofer, B
    Maerz, W
    Lippa, M
    Wahl, HG
    DIABETES, 2005, 54 : A590 - A590